Phenergan 50mg/ml Inj, 1ml

Manufacturer HIKMA PHARMACEUTICALS USA Active Ingredient Promethazine Injection(proe METH a zeen) Pronunciation proe METH a zeen
WARNING: For all patients taking this drug:Severe tissue damage has happened with this drug. Sometimes, this has led to surgery. Tell your doctor or nurse right away if you have any burning, numbness, coldness, color changes (like skin turning red, purple, or black), pain, skin breakdown, pus, or swelling where the shot was given.This drug is injected into the muscle. Some doses may be given into a vein. This drug must not be injected into the fatty tissue under the skin or into an artery.Children:Do not give this drug to a child younger than 2 years of age. It may cause very bad and sometimes deadly breathing problems. Use with care in children 2 years of age and older. Talk with the doctor.Before your child takes this drug, tell the doctor if your child is taking any drugs that can cause breathing problems. There are many drugs that can do this. Ask the doctor or pharmacist if you are not sure. @ COMMON USES: It is used to ease allergy signs.It is used to help motion sickness.It is used to prevent upset stomach and throwing up from surgery.It is used during surgery.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antihistamine, Antiemetic, Sedative
đŸ§Ŧ
Pharmacologic Class
Phenothiazine derivative, H1-receptor antagonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Mar 1951
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Promethazine is a medication that can help with nausea, vomiting, allergies, and can also make you feel sleepy. It works by blocking certain natural substances in your body. It is given as an injection, usually into a muscle, but sometimes into a vein with extreme caution.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and read all the information provided. Take this medication exactly as directed, and carefully follow all instructions. This medication is administered via injection into a muscle or, in some cases, into a vein.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

If you miss a dose, contact your doctor to receive guidance on the appropriate course of action.
💡

Lifestyle & Tips

  • Avoid driving or operating heavy machinery until you know how this medication affects you, as it can cause drowsiness or dizziness.
  • Avoid alcohol and other sedating medications, as they can increase drowsiness and other side effects.
  • Stay hydrated to help with potential dry mouth and constipation.
  • Report any unusual or severe side effects immediately.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Varies by indication. For nausea/vomiting: 12.5-25 mg IM/IV every 4-6 hours as needed. For sedation: 25-50 mg IM/IV at bedtime or preoperatively. For allergic reactions: 25 mg IM/IV, may repeat in 2 hours if needed.
Dose Range: 12.5 - 50 mg

Condition-Specific Dosing:

Nausea and Vomiting: 12.5-25 mg IM/IV every 4-6 hours as needed
Sedation: 25-50 mg IM/IV at bedtime or preoperatively
Allergic Reactions: 25 mg IM/IV, may repeat in 2 hours if needed
Adjunct to Analgesia: 25-50 mg IM/IV with reduced dose of narcotic
đŸ‘ļ

Pediatric Dosing

Neonatal: Contraindicated in patients < 2 years due to risk of fatal respiratory depression.
Infant: Contraindicated in patients < 2 years due to risk of fatal respiratory depression.
Child: For nausea/vomiting: 0.5 mg/kg IM/IV every 4-6 hours as needed (max 25 mg/dose). For sedation: 0.5-1 mg/kg IM/IV at bedtime or preoperatively (max 50 mg/dose).
Adolescent: Same as adult dosing, generally 12.5-25 mg IM/IV every 4-6 hours as needed for nausea/vomiting, or 25-50 mg for sedation.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended.
Moderate: Use with caution; consider lower doses or extended intervals due to potential for accumulation of active metabolites.
Severe: Use with caution; consider lower doses or extended intervals due to potential for accumulation of active metabolites. Monitor for increased sedation and anticholinergic effects.
Dialysis: Promethazine is not dialyzable. Use with caution; monitor for adverse effects.

Hepatic Impairment:

Mild: No specific dose adjustment recommended.
Moderate: Use with caution; consider lower doses or extended intervals due to extensive hepatic metabolism. Monitor for increased sedation and anticholinergic effects.
Severe: Use with caution; consider lower doses or extended intervals due to extensive hepatic metabolism. Monitor for increased sedation and anticholinergic effects.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Promethazine is a phenothiazine derivative that acts as a potent, competitive H1-receptor antagonist. It also possesses significant anticholinergic, sedative, antiemetic, and weak dopamine receptor blocking (D2) properties. Its antiemetic effect is thought to be due to central anticholinergic action and direct inhibition of the chemoreceptor trigger zone (CTZ).
📊

Pharmacokinetics

Absorption:

Bioavailability: Not available (IM/IV route bypasses first-pass metabolism)
Tmax: IM: 20-60 minutes; IV: Immediate
FoodEffect: Not applicable for injection

Distribution:

Vd: 131-337 L (large volume of distribution)
ProteinBinding: 93%
CnssPenetration: Yes

Elimination:

HalfLife: 10-14 hours (range 7-19 hours)
Clearance: Not available
ExcretionRoute: Renal (primarily as inactive metabolites), Fecal (small amounts)
Unchanged: <1% (renal)
âąī¸

Pharmacodynamics

OnsetOfAction: IM: 20 minutes; IV: 3-5 minutes
PeakEffect: IM: 30-60 minutes; IV: 5-10 minutes
DurationOfAction: 4-6 hours (up to 12 hours for sedative effects)
Confidence: High

Safety & Warnings

âš ī¸

BLACK BOX WARNING

RESPIRATORY DEPRESSION: Promethazine should not be used in pediatric patients less than 2 years of age because of the potential for fatal respiratory depression. Postmarketing cases of respiratory depression, including fatalities, have been reported with use of promethazine in pediatric patients less than 2 years of age. Caution should be exercised when administering promethazine to pediatric patients 2 years of age and older. A lower dose of promethazine should be used in pediatric patients 2 years of age and older. SEVERE CHEMICAL IRRITATION AND DAMAGE INCLUDING GANGRENE: Promethazine injection is contraindicated for subcutaneous administration. Intra-arterial injection and perivascular extravasation can result in severe irritation and damage to tissues, including gangrene. The preferred route of administration is by deep intramuscular injection. When given intravenously, it should be given via a large-bore, patent vein, preferably through a running intravenous infusion, in concentrations no greater than 25 mg/mL. The maximum recommended intravenous dose is 25 mg. Rapid intravenous injection should be avoided.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache
+ Dizziness
+ Passing out
+ Changes in eyesight
Abnormal heartbeat (fast or slow)
Trouble controlling body movements, twitching, or changes in balance
Difficulty swallowing or speaking
Shakiness, trouble moving around, or stiffness
Feeling confused
Feeling nervous and excitable
Hallucinations (seeing or hearing things that are not there)
Mood changes
Ringing in the ears
Seizures
Unexplained bruising or bleeding
Yellowing of the skin or eyes
Changes in eyesight
Neuroleptic malignant syndrome (NMS), a rare but potentially life-threatening condition, characterized by:
+ Fever
+ Muscle cramps or stiffness
+ Dizziness
+ Severe headache
+ Confusion
+ Changes in thinking
+ Fast heartbeat
+ Abnormal heartbeat
+ Excessive sweating
Severe breathing problems, including:
+ Slow, shallow, or troubled breathing
Low white blood cell counts, which may increase the risk of infection; seek medical help if you experience:
+ Fever
+ Chills
+ Sore throat

Other Possible Side Effects

While many people may not experience any side effects or only minor ones, it's essential to be aware of the following potential side effects:

Feeling dizzy, sleepy, tired, or weak
Blurred vision
Dry mouth
Upset stomach or vomiting
Trouble sleeping
Stuffy nose

If any of these side effects or other concerns bother you or persist, contact your doctor or seek medical attention. Remember to report any side effects to your doctor or the FDA (1-800-332-1088 or https://www.fda.gov/medwatch).
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe drowsiness or difficulty waking up
  • Very slow or shallow breathing
  • Confusion or disorientation
  • Hallucinations
  • Muscle stiffness, tremors, or uncontrolled movements (e.g., grimacing, tongue protrusion)
  • Fever, sweating, severe muscle stiffness, and confusion (signs of Neuroleptic Malignant Syndrome)
  • Pain, burning, swelling, redness, or blistering at the injection site (especially with IV administration)
  • Yellowing of skin or eyes (jaundice)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction and its symptoms.
Certain health conditions, including:
+ Respiratory problems like asthma, chronic obstructive pulmonary disease (COPD), or sleep apnea (breathing difficulties during sleep).
+ Liver problems or a history of Reye's syndrome.

This list is not exhaustive, and it is crucial to discuss all your health concerns with your doctor.

To ensure safe treatment, please provide your doctor and pharmacist with a comprehensive list of:

All prescription and over-the-counter (OTC) medications you are taking.
Any natural products or vitamins you are using.
* Your complete medical history, including any health problems.

Before starting, stopping, or changing the dose of any medication, including this one, consult with your doctor to confirm it is safe for you to do so.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Before engaging in activities that require alertness and clear vision, such as driving, wait until you understand how this drug affects you.

This medication may interfere with the accuracy of certain pregnancy tests. If you are pregnant or suspect you may be pregnant, consult your doctor to discuss the potential implications.

If you have diabetes, it is crucial to closely monitor your blood sugar levels while taking this medication. Additionally, before consuming alcohol, using marijuana or other cannabis products, or taking prescription or over-the-counter drugs that may cause drowsiness, consult your doctor to discuss potential interactions.

You may be more susceptible to sunburn while taking this medication. To minimize this risk, avoid exposure to direct sunlight, sunlamps, and tanning beds. Use protective measures such as sunscreen, clothing, and eyewear that provide adequate protection against the sun.

This medication may increase the risk of seizures, particularly in individuals with a history of seizure disorders. Consult your doctor to determine if you are at a higher risk of experiencing seizures while taking this drug.

If you have a sulfite allergy, inform your doctor, as some formulations of this medication may contain sulfites.

Older adults (65 years and older) should exercise caution when taking this medication, as they may be more prone to experiencing side effects.

If you are pregnant, planning to become pregnant, or breastfeeding, inform your doctor to discuss the potential benefits and risks of this medication to both you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Severe CNS depression (deep sedation, coma)
  • Respiratory depression
  • Hypotension
  • Tachycardia
  • Anticholinergic effects (dilated pupils, dry mouth, flushed skin, urinary retention, bowel paralysis)
  • Seizures
  • Arrhythmias
  • Extrapyramidal symptoms

What to Do:

Seek immediate medical attention. Call 911 or your local emergency number. For poison control, call 1-800-222-1222. Treatment is supportive, including maintaining airway, assisting ventilation, managing hypotension, and controlling seizures. Physostigmine may be considered for severe anticholinergic symptoms. Avoid epinephrine for hypotension due to paradoxical effect.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • MAO inhibitors (concurrent use or within 14 days of MAOI discontinuation)
  • Other CNS depressants (e.g., opioids, barbiturates, benzodiazepines) in pediatric patients < 2 years
🔴

Major Interactions

  • CNS depressants (e.g., opioids, benzodiazepines, barbiturates, alcohol, tricyclic antidepressants, general anesthetics) - increased sedation, respiratory depression, hypotension
  • Anticholinergic drugs (e.g., atropine, TCAs, other antihistamines) - increased anticholinergic effects (dry mouth, blurred vision, urinary retention, constipation)
  • Dopamine agonists (e.g., bromocriptine, cabergoline) - promethazine's dopamine blocking effects may antagonize their effects
  • QT-prolonging drugs (e.g., antiarrhythmics, some antipsychotics, macrolide antibiotics) - theoretical risk of additive QT prolongation
  • Epinephrine (paradoxical fall in blood pressure with promethazine in overdose)
🟡

Moderate Interactions

  • Antihypertensives - additive hypotensive effects
  • Cholinesterase inhibitors (e.g., donepezil) - promethazine's anticholinergic effects may antagonize their effects
  • Metoclopramide - additive risk of extrapyramidal symptoms
  • Phenytoin - promethazine may alter phenytoin metabolism
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Patient history (allergies, pre-existing conditions like asthma, glaucoma, prostate hypertrophy, cardiovascular disease)

Rationale: To identify contraindications or conditions requiring caution.

Timing: Prior to administration

Medication reconciliation

Rationale: To identify potential drug interactions, especially with CNS depressants or anticholinergic agents.

Timing: Prior to administration

Baseline vital signs (BP, HR, RR, O2 saturation)

Rationale: To establish baseline for monitoring effects of sedation and respiratory depression.

Timing: Prior to administration

📊

Routine Monitoring

Level of consciousness/Sedation score

Frequency: Every 15-30 minutes initially, then as clinically indicated (e.g., every 1-2 hours) until stable

Target: Appropriate level of sedation for indication, avoiding over-sedation

Action Threshold: Excessive sedation, unresponsiveness, difficulty arousing

Respiratory rate and depth, O2 saturation

Frequency: Every 15-30 minutes initially, then as clinically indicated (e.g., every 1-2 hours) until stable

Target: Age-appropriate respiratory rate, O2 saturation >92-94%

Action Threshold: Respiratory depression (<10 breaths/min in adults), shallow breathing, O2 saturation <90%

Blood pressure and heart rate

Frequency: Every 15-30 minutes initially, then as clinically indicated (e.g., every 1-2 hours) until stable

Target: Within patient's normal range

Action Threshold: Significant hypotension or bradycardia/tachycardia

Injection site assessment (for IV administration)

Frequency: Continuously during infusion, then regularly post-infusion

Target: No signs of irritation, pain, swelling, redness, or extravasation

Action Threshold: Any signs of pain, burning, swelling, redness, or extravasation; discontinue immediately and manage extravasation.

đŸ‘ī¸

Symptom Monitoring

  • Excessive sedation
  • Respiratory depression (slow, shallow breathing)
  • Dizziness
  • Confusion
  • Dry mouth
  • Blurred vision
  • Urinary retention
  • Constipation
  • Extrapyramidal symptoms (rare: dystonia, akathisia, parkinsonism)
  • Neuroleptic Malignant Syndrome (rare: fever, muscle rigidity, altered mental status, autonomic instability)
  • Injection site pain, burning, swelling, redness, blistering, tissue necrosis (especially with IV administration)

Special Patient Groups

🤰

Pregnancy

Promethazine is Pregnancy Category C. Use during pregnancy should only be considered if the potential benefit justifies the potential risk to the fetus. Limited human data suggest no increased risk of major birth defects, but some studies suggest a possible association with congenital malformations when used in the first trimester. Use near term may cause respiratory depression or extrapyramidal symptoms in the neonate.

Trimester-Specific Risks:

First Trimester: Possible association with congenital malformations (conflicting data), generally avoided unless clearly needed.
Second Trimester: Generally considered safer than first or third trimester, but still use with caution.
Third Trimester: Risk of respiratory depression, hypotonia, or extrapyramidal symptoms in the neonate if used close to delivery.
🤱

Lactation

Promethazine is excreted into breast milk. The American Academy of Pediatrics considers it to be of 'concern' due to potential for sedation and anticholinergic effects in the infant. Use with caution, monitor infant for drowsiness, irritability, or poor feeding. Avoid in preterm or jaundiced infants.

Infant Risk: L3 (Moderate risk) - Potential for sedation, irritability, or anticholinergic effects in the infant. Avoid if possible, or use lowest effective dose for shortest duration. Monitor infant closely.
đŸ‘ļ

Pediatric Use

Contraindicated in patients less than 2 years of age due to the risk of fatal respiratory depression. Use with extreme caution in pediatric patients 2 years of age and older; use the lowest effective dose and avoid concomitant use of other respiratory depressants. Risk of extrapyramidal symptoms and paradoxical excitation (restlessness, agitation) is higher in pediatric patients.

👴

Geriatric Use

Use with caution in elderly patients due to increased susceptibility to anticholinergic effects (e.g., dry mouth, blurred vision, urinary retention, constipation), sedation, dizziness, and hypotension. Start with lower doses and titrate slowly. Increased risk of falls. May exacerbate underlying conditions like glaucoma or prostatic hypertrophy.

Clinical Information

💎

Clinical Pearls

  • **Black Box Warning:** Absolutely contraindicated in children < 2 years due to fatal respiratory depression. Use extreme caution in children â‰Ĩ 2 years.
  • **IV Administration:** The preferred route is deep IM injection. IV administration carries a black box warning for severe tissue injury (gangrene, necrosis) due to extravasation or intra-arterial injection. If IV is necessary, use a large, patent vein, dilute to ≤ 25 mg/mL, administer slowly (no faster than 25 mg/min), and ensure the patient reports any pain or burning immediately.
  • **Sedation:** Promethazine is a potent sedative. Warn patients about impaired ability to drive or operate machinery. Avoid concomitant use with alcohol or other CNS depressants.
  • **Anticholinergic Effects:** Be mindful of anticholinergic side effects, especially in elderly patients or those with pre-existing conditions like glaucoma, BPH, or bowel obstruction.
  • **Extrapyramidal Symptoms (EPS):** While less common than with typical antipsychotics, promethazine can cause EPS, especially at higher doses or in susceptible individuals (e.g., children).
  • **Photosensitivity:** Advise patients to use sun protection as promethazine can cause photosensitivity.
🔄

Alternative Therapies

  • For nausea/vomiting: Ondansetron, Metoclopramide, Prochlorperazine, Dimenhydrinate
  • For allergic reactions: Diphenhydramine, Hydroxyzine, Cetirizine, Loratadine
  • For sedation: Diphenhydramine, Hydroxyzine, Benzodiazepines (e.g., Lorazepam, Midazolam)
  • For adjunct to analgesia: Hydroxyzine
💰

Cost & Coverage

Average Cost: Varies widely per 1ml vial
Generic Available: Yes
Insurance Coverage: Tier 1 or 2 (Generic)
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed to someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, do not flush medications down the toilet or drain. If you are unsure about the correct disposal method, consult your pharmacist for guidance. Many communities offer drug take-back programs, which your pharmacist can help you locate. Some medications may come with an additional patient information leaflet; check with your pharmacist for more information. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken to ensure prompt and effective treatment.